Literature DB >> 21903279

GPCR agonist binding revealed by modeling and crystallography.

Vsevolod Katritch1, Ruben Abagyan.   

Abstract

Despite recent progress in structural coverage of the G-protein-coupled receptor (GPCR) family, high plasticity of these membrane proteins poses additional challenges for crystallographic studies of their complexes with different classes of ligands, especially agonists. The ability to predict computationally the binding of natural and clinically relevant agonists and corresponding changes in the receptor pocket, starting from inactive GPCR structures, is therefore of great interest for understanding GPCR biology and drug action. Comparison of computational models published in 2009 and 2010 with recently determined agonist-bound structures of β-adrenergic and adenosine A(2A) receptors reveals high accuracy of the predicted agonist binding poses (0.8 Å and 1.7 Å respectively) and receptor interactions. In the case of the β(2)AR, energy-based models with limited backbone flexibility have also allowed characterization of side-chain rotations and a finite backbone shift in the pocket region as determinants of full, partial or inverse agonism. Development of accurate models of agonist binding for other GPCRs will be instrumental for functional and pharmacological studies, complementing biochemical and crystallographic techniques.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21903279      PMCID: PMC3200445          DOI: 10.1016/j.tips.2011.08.001

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  62 in total

1.  Selective structure-based virtual screening for full and partial agonists of the beta2 adrenergic receptor.

Authors:  Chris de Graaf; Didier Rognan
Journal:  J Med Chem       Date:  2008-08-05       Impact factor: 7.446

2.  Development and crystallization of a minimal thermostabilised G protein-coupled receptor.

Authors:  Tony Warne; Maria J Serrano-Vega; Christopher G Tate; Gebhard F X Schertler
Journal:  Protein Expr Purif       Date:  2009-06       Impact factor: 1.650

3.  Catechol-binding serines of beta(2)-adrenergic receptors control the equilibrium between active and inactive receptor states.

Authors:  C Ambrosio; P Molinari; S Cotecchia; T Costa
Journal:  Mol Pharmacol       Date:  2000-01       Impact factor: 4.436

4.  Crystal structure of opsin in its G-protein-interacting conformation.

Authors:  Patrick Scheerer; Jung Hee Park; Peter W Hildebrand; Yong Ju Kim; Norbert Krauss; Hui-Woog Choe; Klaus Peter Hofmann; Oliver P Ernst
Journal:  Nature       Date:  2008-09-25       Impact factor: 49.962

5.  Use of the X-ray structure of the beta2-adrenergic receptor for drug discovery. Part 2: Identification of active compounds.

Authors:  Michael Sabio; Kenneth Jones; Sid Topiol
Journal:  Bioorg Med Chem Lett       Date:  2008-09-14       Impact factor: 2.823

6.  Four-dimensional docking: a fast and accurate account of discrete receptor flexibility in ligand docking.

Authors:  Giovanni Bottegoni; Irina Kufareva; Maxim Totrov; Ruben Abagyan
Journal:  J Med Chem       Date:  2009-01-22       Impact factor: 7.446

7.  Structure of a beta1-adrenergic G-protein-coupled receptor.

Authors:  Tony Warne; Maria J Serrano-Vega; Jillian G Baker; Rouslan Moukhametzianov; Patricia C Edwards; Richard Henderson; Andrew G W Leslie; Christopher G Tate; Gebhard F X Schertler
Journal:  Nature       Date:  2008-06-25       Impact factor: 49.962

8.  High-resolution distance mapping in rhodopsin reveals the pattern of helix movement due to activation.

Authors:  Christian Altenbach; Ana Karin Kusnetzow; Oliver P Ernst; Klaus Peter Hofmann; Wayne L Hubbell
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-19       Impact factor: 11.205

9.  The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.

Authors:  Veli-Pekka Jaakola; Mark T Griffith; Michael A Hanson; Vadim Cherezov; Ellen Y T Chien; J Robert Lane; Adriaan P Ijzerman; Raymond C Stevens
Journal:  Science       Date:  2008-10-02       Impact factor: 47.728

10.  Identification of two distinct inactive conformations of the beta2-adrenergic receptor reconciles structural and biochemical observations.

Authors:  Ron O Dror; Daniel H Arlow; David W Borhani; Morten Ø Jensen; Stefano Piana; David E Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-03       Impact factor: 11.205

View more
  16 in total

1.  Rescue of misrouted GnRHR mutants reveals its constitutive activity.

Authors:  Jo Ann Janovick; Irina D Pogozheva; Henry I Mosberg; Anda Cornea; P Michael Conn
Journal:  Mol Endocrinol       Date:  2012-05-17

2.  A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design.

Authors:  A J Kooistra; S Kuhne; I J P de Esch; R Leurs; C de Graaf
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

3.  Advances in GPCR modeling evaluated by the GPCR Dock 2013 assessment: meeting new challenges.

Authors:  Irina Kufareva; Vsevolod Katritch; Raymond C Stevens; Ruben Abagyan
Journal:  Structure       Date:  2014-07-24       Impact factor: 5.006

4.  Chemotype-selective modes of action of κ-opioid receptor agonists.

Authors:  Eyal Vardy; Philip D Mosier; Kevin J Frankowski; Huixian Wu; Vsevolod Katritch; Richard B Westkaemper; Jeffrey Aubé; Raymond C Stevens; Bryan L Roth
Journal:  J Biol Chem       Date:  2013-10-11       Impact factor: 5.157

5.  Computational studies to predict or explain G protein coupled receptor polypharmacology.

Authors:  Kenneth A Jacobson; Stefano Costanzi; Silvia Paoletta
Journal:  Trends Pharmacol Sci       Date:  2014-11-14       Impact factor: 14.819

6.  Functional anatomy of the full-length CXCR4-CXCL12 complex systematically dissected by quantitative model-guided mutagenesis.

Authors:  Bryan S Stephens; Tony Ngo; Irina Kufareva; Tracy M Handel
Journal:  Sci Signal       Date:  2020-07-14       Impact factor: 8.192

Review 7.  Diversity and modularity of G protein-coupled receptor structures.

Authors:  Vsevolod Katritch; Vadim Cherezov; Raymond C Stevens
Journal:  Trends Pharmacol Sci       Date:  2011-10-25       Impact factor: 14.819

8.  Probing GPCR structure: adenosine and P2Y nucleotide receptors.

Authors:  Kenneth A Jacobson; Stefano Costanzi; Francesca Deflorian
Journal:  Methods Enzymol       Date:  2013       Impact factor: 1.600

9.  Detailed analysis of biased histamine H₄ receptor signalling by JNJ 7777120 analogues.

Authors:  S Nijmeijer; H F Vischer; F Sirci; S Schultes; H Engelhardt; C de Graaf; E M Rosethorne; S J Charlton; R Leurs
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

10.  G Protein-Coupled Estrogen Receptor (GPER) Agonist Dual Binding Mode Analyses toward Understanding of its Activation Mechanism: A Comparative Homology Modeling Approach.

Authors:  Christopher K Arnatt; Yan Zhang
Journal:  Mol Inform       Date:  2013-07       Impact factor: 3.353

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.